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IMR was measured in 34 patients (one patient was excluded for a
technical problem). 56% of the patients were males with a mean age
of 70þ/-15 years. All procedures were performed by radial approach.
Pressure wire physiological measurements demonstrated a
signiﬁcant MD. IMR showed a median value of 32þ/-16 with normal
IMR in healthy humans being< 20-30U (median value of 12.6).
Coronary ﬂow reserve (CFR) was also concordant with a MD and
statistically associated with IMR (r¼ -04 p 0.03). A signiﬁcant
association between IMR and BNP levels were found (r¼ -0.4,
p 0.02). A nonsigniﬁcant correlation with age and IMR was found
(r¼ 0.32, p 0.06). Interestingly a signiﬁcantly lower IMR was found
in patients in treatment with beta-blockers (p 0,013). No signiﬁcant
relationship between IMR other clinical, biochemical, physiological
or echocardiogram parameters were found.
Table 1Characteristics Percentage/ValueDiabetes 26%Hypertension 57%Atrial ﬁbrillation 11,7%Severe aortic calciﬁcation 16%Beta blocker treatment 40%Oligosymptomatic 8,5%FFR<0.75 in LAD 3%Body mass index 28,9 þ/- 4.5 kg/m2
LV ejection fraction 62 þ/- 8.4 %
Mean gradient 53 þ/- 16 mm/Hg
Index AVA 0,44þ/- 11 cm2/m2
Ejection Time 0,299 þ/- 59 sec.
FFR 0,87 þ/- 0.8
CFR 1,39 þ/- 0.6CONCLUSIONS Invasive IMR measurement conﬁrm that patients with
AS have a high coronary resistance and MD. IMR showed a median
value of 32þ/-16 and was statistically associated with CFR and with
BNP levels. Interestingly a signiﬁcantly lower IMR was found in pa-
tients in treatment with beta-blockers.
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BACKGROUND Fractional ﬂow reserve (FFR) is useful for determining
the functional signiﬁcance of epicardial coronary stenosis and may
facilitate clinical decision making in patients with an equivocal cor-
onary stenosis. Therefore, determining an efﬁcient and safe method
to achieve hyperemia is important for evaluating FFR.
METHODS We evaluated appropriate hyperemic dose of nicorandil
(NIC) in 42 vessels (LAD:27 vessels, CX:8 vessels, RCA: 7 vessels) of 30
patients. Next, we compared the FFR induced by ATP and by 2-mg NIC
in 170 vessels of 129 Japanese patients. Finally, we examined effect of
adding NIC to ATP to evaluate FFR in 41 vessels (LAD:31 vessels, CX:4
vessels, RCA: 6 vessels) of another 35 patients.
RESULTS 76.2% of vessels achieved hyperemia with 2-mg NIC. If an
accidental error was deﬁned as a difference of 0.01 in the FFR mea-
surements, hyperemia was achieved in 95.2% vessels when up to 2-mg
NIC was administered. The FFR values obtained with ATP were
signiﬁcantly correlated with those obtained with 2-mg NIC (regression
coefﬁcient ¼ 0.960, R2 ¼ 0.918, P < 0.001). FFR value were not
different in size of catheter (4Fr vs 5,6Fr), site of approach (TR vs
TB,TF), and type of catheter (sones vs others). There were one hy-
potension case needing a vasopressor and two cases of transient
second-degree atrioventricular block after ATP administration but
not after NIC administration (0.6% vs 0.0%, 1.2% vs 0.0%, not
signiﬁcantly). The time taken to achieve hyperemia after NIC
administration (17.78.7 s) was signiﬁcantly shorter than that afterATP administration (196.526.0 s) (P < 0.001). Adding 2-mg NIC to
ATP reduced FFR value, -0.0170.035, but not reaching signiﬁcance.
Reductions of FFR value were not different in size of catheter (4Fr vs
5,6Fr), site of approach (TR vs TB,TF), and type of catheter (sones vs
others), but FFR value in non LAD came down more than LAD (non-
LAD : -0.0380.034, LAD：-0.0100.033, p¼0.036).
CONCLUSIONS Intracoronary nicorandil administration is more use-
ful than and as safe as intravenous administration of ATP for evalu-
ating FFR in Japanese patients.
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BACKGROUND Fractional ﬂow reserve (FFR) measurement is being
used increasingly in patients with coronary artery disease to guide
treatment. However, limited data are available on the contemporary
utilization rates and in-hospital outcomes of FFR measurement in
patients with non-ST-elevation myocardial infarction (NSTEMI).
METHODS We queried the 2009-2012 National Inpatient Sample (NIS)
databases to identify all patients admitted with the primary diagnosis
of NSTEMI (ICD-9-CM code 410.71). Multivariate logistic regression
and linear regression models were used to analyze the utilization rates
and in-hospital outcomes of FFR measurement in NSTEMI patients
undergoing coronary angiography.
RESULTS Of 1,605,295 (57.7% men, mean age 6914 years) patients
hospitalized with NSTEMI from 2009-2012, 992,183 (61.8%) under-
went coronary angiography. Among NSTEMI patients who underwent
coronary angiography, FFR measurement was performed in 9,086
(0.9%) patients. FFR utilization rates increased from 0.4% in 2009 to
1.5% in 2012 (adjusted OR per year, 1.46; 95% CI, 1.43-1.49; p<0.001).
Among NSTEMI patients who underwent coronary angiography, those
who had FFR measurement performed were less likely to undergo
percutaneous coronary intervention (PCI) (54.2% vs 54.4%; adjusted
OR, 0.91; 95% CI, 0.87-0.95, p<0.001) or coronary artery bypass
grafting (CABG) (9.9% vs 11.5%; adjusted OR, 0.79; 95% CI, 0.73-0.85,
p<0.001) compared to those who did not have FFR measured. In-
hospital mortality was lower (0.8% vs. 1.8%; adjusted OR, 0.53; 95%
CI, 0.42-0.67, p<0.001) and average length of stay was shorter (4.4
days vs 4.8 days; adjusted parameter estimate 0.96; 95% CI 0.95-0.98;
p<0.001) in FFR group compared to the no FFR group. Average total
hospital charges were higher in the FFR group compared to the no FFR
group ($82,621 vs $79,019; adjusted parameter estimate 1.05; 95% CI
1.04-1.07; p<0.001).
CONCLUSIONS In NSTEMI patients undergoing coronary angiog-
raphy, although we observed an increasing trend in the use of FFR
measurement over the last few years, the absolute utilization rates
remain exceedingly low. FFR measurement during coronary angiog-
raphy is associated with lower revascularization rates, lower in-hos-
pital mortality, shorter average length of stay, but higher average
hospital charges.
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BACKGROUND Coronary physiologic methods like coronary ﬂow
reserve, fractional ﬂow reserve and the index of microvascular resis-
tance (IMR) have emerged as complementary methods to angiography
and intravascular ultrasound for assessing the physiological status of
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method is speciﬁc to the microvasculature, and it has been validated
in animal studies and investigated further in human studies.
Comprehensive calculation of IMR requires correction for venous
pressure and collateral epicardial ﬂow. This is not done routinely,
primarily due to the time required and risk of adverse events. Theo-
retically, when the collateral ﬂow and venous pressures are both low,
the discrepancy between simpliﬁed (IMRs) and comprehensive (IMRc)
IMR calculations is small. However, it is not known whether the IMRs
method is a good approximation for IMRc in HTx recipients. The
objective of the present study was to assess (1) the agreement between
the two methods at both 7–11 weeks and 1 year post-HTx, and (2) the
changes in IMR from 7–11 weeks to 1 year post-HTx using the two
approaches.
METHODS In total, 48 patients were randomized in the study. All
patients underwent left- and right-heart catheterization with coro-
nary physiological evaluations at 7–11 weeks and 1 year after HTx.
IMRs was calculated as the product of hyperemic mean transit time
and distal coronary pressure while additionally including coronary
wedge pressure and right atrial pressure in calculation of IMRc. The
agreement between the values of IMR at the two time points using the
IMRs and IMRc methods and change was assessed using Bland-Altman
analysis and estimated from a linear mixed model.
RESULTS Mean IMRs declined signiﬁcantly over time, from
18.7 mmHg$s (95% CI¼16.2–21.1 mmHg$s) at 7–11 weeks to
15.9 mmHg$s (95% CI¼13.4–18.3 mmHg$s) at 1 year (p¼0.03), while the
decline in the mean IMRc from 16.9 mmHg$s (95% CI¼14.5–
19.2 mmHg$s) to 15.0 mmHg$s (95% CI¼12.7–17.3 mmHg$s) was not
statistically signiﬁcant (p¼0.13). Bias between the IMRs and IMRc
calculations was estimated to be 1.3 mmHg$s (p<0.01). The 95% limits
of agreement –1.2 to þ3.8 mmHg$s. The average difference between
the IMRs and IMRc calculations was signiﬁcantly different from zero
at 7–11 weeks (p¼0.04) but not at 1 year (p¼0.24) post-HTx.Time after Htx
*p7-11 weeks 1 yearIMRs mmHg$s 18.7 (16.2-21.1) 15.9 (13.4-18.3) 0.03IMRc mmHg$s 16.9 (14.5-19.2) 15.0 (12.7-17.3) 0.13*p 0.04 0.24CONCLUSIONS The IMRs method resulted in slightly higher IMR es-
timates than the IMRc method, and exhibited a somewhat greater
change over the 10-month follow-up period. However, the difference
(bias) between the methods was only 1.3 mmHg$s and is unlikely to be
of clinical importance. Therefore, it can be concluded that IMRs can be
used as an approximation for IMRc.
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BACKGROUND Fractional ﬂow reserve (FFR) is useful in deﬁning the
physiological signiﬁcance of intermediate stenosis, and requires
measurement of pressure proximal to and distal to the stenosis in
conditions of maximal hyperemia. This is induced by intracoronary or
intravenous (IV) adenosine. Regadenoson, which has an improved
safety proﬁle compared to adenosine, is approved for use in phar-
macologic myocardial perfusion imaging. This meta-analysis aims to
evaluate the efﬁcacy and safety of regadenoson, in comparison with
adenosine, for assessing FFR.
METHODS A systematic literature search of 210 potentially relevant
citations from PubMed, EMBASE, Web of Science and the CochraneCentral Register of Controlled Trials yielded 4 eligible studies con-
taining comparison data on regadenoson and adenosine.
RESULTS Four studies were included in the analysis, with a total of
202 patients undergoing elective coronary angiography. The mean
correlation coefﬁcient between FFR values induced by IV adenosine
and IV regadenoson was 0.97  0.03. The overall mean FFR of IV
adenosine and IV regadenoson were both similar at 0.80  0.04. Time
to FFR nadir was shorter for regadenoson compared to adenosine with
43.2  13.7 and 78.2  13.7 seconds (p¼0.01), respectively. Regade-
noson, compared to adenosine, had numerically lower rate of ﬂushing
(8.2% vs 18.8%), nausea (1.2% vs 8.1%), headache (5.9% vs 8.2%), and
transient heart block (0.5% vs 4.3%).
Table. Adverse Events After Adenosine and RegadenosonAdenosine (%) Regadenoson (%)Flushing 16/85 (18.8) 7/85 (8.2)Nausea 6/85 (7.1) 1/85 (1.2)Headache 7/85 (8.2) 5/85 (5.9)Transient heart block 9/205 (4.3) 1/205 (0.5)Shortness of breath 4/105 (3.8) 3/105 (2.9)Chest pain 0/80 (0) 0/80 (0)Chest discomfort 8/25 (32.0) 5/25 (20.0)Dizziness 3/60 (5.0) 1/60 (1.7)CONCLUSIONS Our composite data suggest that regadenoson pro-
duces similar pressure-derived FFR compared to adenosine, achieves
a more rapid hyperemia, and has a favorable side-effect proﬁle.
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BACKGROUND Despite the widespread adoption of intracoronary (IC)
adenosine in clinical practice, no wide-ranging, dose-response study
